0001181431-13-013837.txt : 20130304 0001181431-13-013837.hdr.sgml : 20130304 20130304130718 ACCESSION NUMBER: 0001181431-13-013837 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130301 FILED AS OF DATE: 20130304 DATE AS OF CHANGE: 20130304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clovis Oncology, Inc. CENTRAL INDEX KEY: 0001466301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900475355 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 28TH STREET STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (303) 625-5000 MAIL ADDRESS: STREET 1: 2525 28TH STREET STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAST ERLE T CENTRAL INDEX KEY: 0001051411 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35347 FILM NUMBER: 13660782 MAIL ADDRESS: STREET 1: C/O SPIROS DEVELOPMENT CORP II INC STREET 2: 7475 LUSK BLVD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 rrd372560.xml FORM 4 X0306 4 2013-03-01 0 0001466301 Clovis Oncology, Inc. CLVS 0001051411 MAST ERLE T C/O CLOVIS ONCOLOGY, INC. 2525 28TH STREET, SUITE 100 BOULDER CO 80301 0 1 0 0 Executive VP and CFO Stock Option (right to buy) 21.81 2013-03-01 4 A 0 75000 0 A 2023-03-01 Common Stock 75000 75000 D The option shall vest as to 25% of the shares on March 1, 2014 and the remainder shall vest in substantially equal installments over the 36 months immediately following such date. /s/ Erle T. Mast 2013-03-01